BE885113A - Compositions pour le traitement des etats de resorption minerale pathologiques et leur utilisation - Google Patents

Compositions pour le traitement des etats de resorption minerale pathologiques et leur utilisation

Info

Publication number
BE885113A
BE885113A BE0/202008A BE202008A BE885113A BE 885113 A BE885113 A BE 885113A BE 0/202008 A BE0/202008 A BE 0/202008A BE 202008 A BE202008 A BE 202008A BE 885113 A BE885113 A BE 885113A
Authority
BE
Belgium
Prior art keywords
compositions
treatment
conditions
mineral resorption
pathological
Prior art date
Application number
BE0/202008A
Other languages
English (en)
Inventor
J Horton
W Wechter
Original Assignee
Horton John E
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horton John E, Upjohn Co filed Critical Horton John E
Publication of BE885113A publication Critical patent/BE885113A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
BE0/202008A 1979-09-07 1980-09-05 Compositions pour le traitement des etats de resorption minerale pathologiques et leur utilisation BE885113A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7340079A 1979-09-07 1979-09-07
US7339879A 1979-09-07 1979-09-07

Publications (1)

Publication Number Publication Date
BE885113A true BE885113A (fr) 1981-03-05

Family

ID=26754428

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202008A BE885113A (fr) 1979-09-07 1980-09-05 Compositions pour le traitement des etats de resorption minerale pathologiques et leur utilisation

Country Status (8)

Country Link
JP (1) JPS5649317A (fr)
AU (1) AU532512B2 (fr)
BE (1) BE885113A (fr)
DE (1) DE3033545A1 (fr)
FR (1) FR2464716B1 (fr)
GB (1) GB2058564B (fr)
IT (1) IT1174303B (fr)
NL (1) NL8004904A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764334A (en) * 1983-10-17 1988-08-16 Westinghouse Electric Corp. Visual inspection system for radioactive fuel assemblies using fiberoptics
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease
US4911931A (en) * 1987-08-03 1990-03-27 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US6037339A (en) 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
JP2001510450A (ja) * 1996-10-23 2001-07-31 ザイモジェネティクス,インコーポレイテッド 骨欠損状態を処置するための組成物および方法
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
EP1162890B1 (fr) 1998-10-30 2005-10-12 RJ Innovation Methode de prevention de l'hypocalcemie obstetrique chez les animaux et compositions utilisees dans la dite methode
WO2000067708A2 (fr) * 1999-05-07 2000-11-16 Board Of Regents, The University Of Texas System Compositions d'hormones steroides a administration orale et methodes d'utilisation
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CN111602630A (zh) * 2020-06-24 2020-09-01 山西农业大学 呕吐毒素致肉鸡小肠机械性损伤模型的建立方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4029761A (en) * 1974-10-19 1977-06-14 Fisons Limited Method for treating gingivitis
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones

Also Published As

Publication number Publication date
AU532512B2 (en) 1983-10-06
FR2464716B1 (fr) 1985-10-25
IT8049625A0 (it) 1980-09-05
FR2464716A1 (fr) 1981-03-20
DE3033545A1 (de) 1981-04-02
JPS5649317A (en) 1981-05-02
AU6184380A (en) 1981-03-12
IT1174303B (it) 1987-07-01
NL8004904A (nl) 1981-03-10
GB2058564B (en) 1983-10-26
GB2058564A (en) 1981-04-15

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE870055A (fr) Compositions et procede pour le traitement des calculs renaux
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
NO803722L (no) Gjenstand for utdeling av kondisjoneringsmiddel for toeybehandling
FR2458287B1 (fr) Appareillage destine au traitement de l'ascite
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
BE884917A (fr) Agent pour le traitement de theilerioses et son application
BE885113A (fr) Compositions pour le traitement des etats de resorption minerale pathologiques et leur utilisation
FR2340122A1 (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE890433A (fr) Composition cosmetique pour le traitement local de la cellulite
BE840614A (fr) Compositions pour le traitement des etoffes
BE873004A (fr) Compositions degraissantes pour le traitement de surfaces metalliques
BE851775A (fr) Composition pour le traitement de la chevelure
BE873092A (fr) Composition pour le traitement de l'hypertension
BE884537A (fr) Traitement des effluants de carbonylation
BE885290A (fr) Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
BE872382A (fr) Compositions de cuivre pour application topique et leur utilisation dans le traitement des deficiences en cuivre chez les animaux
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE858692A (fr) Composition pour le traitement de l'acne
RO77326A (fr) Procede pour la preparation des esters phosphoriques et thionophosphoniques de 5(3)-hydroxypyrazoles
BE864979A (fr) Compositions pour le traitement des etats asthmatiques
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
FR2537710B1 (fr) Structure d'entree pour tambours rotatifs pour le traitement thermique de matieres

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HORTON JOHN E.

Effective date: 19870930

Owner name: THE UPJOHN CY

Effective date: 19870930